University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Red Evicel

Hospital use only

Status: Red Evolocumab

& Homozygous familial hypercholesterola EMIA in line with NHS England SSC 1649

To be used in line with NICE TA

Status: Amber Evra (patches)

Umbrella service only - patients with compliance problems and metabolic problems

Status: Green Felodipine tablets

Brand rationalisation, APC preferred brands: Cardioplen XL, Felotens XL 

Status: Red Fentanyl lozenges

For palliative care use only

Status: Red Fentanyl sublinual tablets

For palliative care use only

Status: Amber Ferric maltol (Feraccru®)

For the treatment of iron deficiency anaemia (IDA) in patients with inflammatory bowel disease (IBD), unable to tolerate other oral iron formulations.

Supported by a RICaD

Status: Green Ferrous gluconate tablets

If patient intolerant of sulphate.

Status: Green Ferrous sulphate tablets

High relative cost.

Status: Green Fexofenadine

High relative cost

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top